Getting a medicine to a German patient runs through a tightly regulated chain — full-line wholesalers, community pharmacies, hospital tenders and rebate contracts. Which channel fits depends entirely on your product type. Here's how it works.
German prescription supply runs from manufacturer to patient through full-line wholesalers (Phoenix, Alliance Healthcare / Gehe, Sanacorp, Noweda) into roughly 18,000 community pharmacies, under GDP and EU serialization (securPharm / FMD). Hospitals are supplied separately through hospital pharmacies and tenders, and the statutory generics market runs on rebate contracts (Rabattvertraege) between manufacturers and sick funds. A patented specialty, a retail Rx, a biosimilar and a generic each imply a different partner and a different motion.
Once a medicine is authorized and priced, the channel decides whether it actually reaches patients — and the German channel is unusually structured.
Prices are regulated, ownership of pharmacies is restricted, wholesalers operate on fixed margins, and hospitals and retail run on separate systems. For a foreign manufacturer, “distribution” is therefore a set of strategic choices about partners and channels, not a shipping problem to solve at the end.
Choose the wrong channel for your product type and even a well-priced drug stalls at the last mile.
The retail Rx path is the backbone. Each handoff is regulated, and each is a decision about who you partner with.
Or an importer & QP-release site for products made outside the EU.
Carries the whole assortment; delivers to pharmacies multiple times a day.
~18,000 Apotheken; dispenses the prescription to the patient.
Covered by statutory or private insurance.
Inpatient supply bypasses community pharmacies: manufacturers supply hospital pharmacies directly or via wholesalers, largely through tender procedures.
The right channel depends entirely on product type — a hospital specialty, a retail Rx, a biosimilar and a generic each travel a different way.
Germany's prescription supply is anchored by a handful of full-line wholesalers (Vollgrosshaendler) that stock the complete range and deliver to pharmacies several times daily.
Wholesaler margins on prescription medicines are regulated, so this layer competes on service and reliability rather than price. For most retail products, reaching the full-line wholesalers is what puts you within reach of every pharmacy in the country — but specialty and high-cost products often use direct or specialist distribution instead.
Inpatient medicines run on a separate system. Hospitals are supplied through their own hospital pharmacies (Krankenhausapotheken) — either in-house or serving several hospitals — and purchasing is heavily driven by tenders and negotiated agreements.
Winning hospital business is therefore a procurement and key-account exercise, not a retail one: clinical champions, pharmacy and controlling all weigh in, and price competition can be intense. A product used in both settings needs two distinct plans.
The whole chain operates under compliance rules that a distribution partner must meet — and that you must verify before appointing one.
Storage and transport under EU GDP, with validated cold chain for biologics, vaccines and temperature-sensitive products — documented end to end.
The German implementation of the EU Falsified Medicines Directive: a unique identifier and tamper-evidence on each pack, verified and decommissioned at dispense.
For imported products, the importation, QP-release and serialization setup has to exist before the first pack ships — it's a common bottleneck, not a formality.
In a focused session we match your product type to the right channel and partners — wholesalers, hospital routes or rebate strategy — check compliance readiness, and give you a shortlist worth approaching first.